Mel Sorensen - May 1, 2025 Form 4 Insider Report for Galera Therapeutics, Inc. (GRTX)

Role
President and CEO, Director
Signature
/s/ J. Mel Sorensen
Stock symbol
GRTX
Transactions as of
May 1, 2025
Transactions value $
$0
Form type
4
Date filed
5/5/2025, 04:17 PM
Previous filing
Aug 20, 2024
Next filing
Nov 24, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sorensen Mel President and CEO, Director C/O GALERA THERAPEUTICS, INC., 101 LINDENWOOD DRIVE, SUITE 225, MALVERN /s/ J. Mel Sorensen 2025-05-05 0001444783

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTX Stock Option (Right to Buy) Award $0 +6M $0.00 6M May 1, 2025 Common Stock 6M $0.02 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in 48 substantially equal monthly installments with the first installment vesting on June 1, 2025.